Loading insider details...
Beta
Latest Form 4 (Nov 8, 2024): Sale of 3,080,000 TNGX shares, $9.67M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 8, 2024 | Tango Therapeutics, Inc. (TNGX) | Sale | 3,080,000 | $9.67M |
| Oct 28, 2024 | Tango Therapeutics, Inc. (TNGX) | Sale | 633,000 | $4.35M |
| Oct 24, 2024 | Tango Therapeutics, Inc. (TNGX) | Sale | 625,000 | $4.41M |
| Sep 6, 2024 | Tango Therapeutics, Inc. (TNGX) | Other (see footnotes) | 65,000 | n/a |
| Jul 3, 2024 | Tango Therapeutics, Inc. (TNGX) | Sale | 29,000 | $248.5K |
| Jun 13, 2024 | iTeos Therapeutics, Inc. (ITOS) | Grant/Award | 24,200 | n/a |
| Jun 8, 2024 | Tango Therapeutics, Inc. (TNGX) | Sale | 63,000 | $456.1K |
| May 14, 2024 | iTeos Therapeutics, Inc. (ITOS) | Grant/Award | 1,142,857 | $20.00M |
| May 4, 2024 | Tango Therapeutics, Inc. (TNGX) | Sale | 75,000 | $557.3K |
| Feb 8, 2024 | Tyra Biosciences, Inc. (TYRA) | Grant/Award | 63,412 | $825.0K |